NEFL and myeloid sarcoma: First, elevated and correlating levels of light chain neurofilament (NF-L), a specific component of the neuronal cytoskeleton, have been found in the CSF and blood of individuals with MS [25], predicting both clinical deterioration and BVL over long-term evaluation periods [26,27,28].